ROANOKE, Va.--(BUSINESS WIRE)--Luna Innovations Incorporated (NASDAQ:LUNA) announced today that it has entered into a joint marketing alliance agreement with Terumo Cardiovascular Systems Corporation (Terumo CVS). Under the terms of this agreement, Luna and Terumo CVS will market Luna’s EDAC™ (Emboli Detection and Classification) QUANTIFIER for clinical use in the United States. Terumo CVS is the world’s leading supplier of products for cardiopulmonary bypass.
